Recent technological advances have enabled the development of a wide range of increasingly sophisticated wearable and ...

Paradromics implanted—then removed—the device in an epileptic patient. The goal is to help people with conditions like ALS.

Neuralink competitor Paradromics plans to conduct the first clinical trial of its Connexus brain implant later this year.

Neuroscientists can now make precise genetic tweaks to the neurons that are most affected by brain diseases such as Parkinson ...

Paradromics, a brain-computer-interface startup, inserted its brain implant in a person—briefly—in an early test of its ...

Spinal cord stimulation has been used for more than 50 years treat a variety of chronic pain conditions. Advances in technology and cost effectiveness have made this treatment a viable option to ...

Diseases involving the spinal cord include a heterogeneous group of abnormalities, including those of inflammatory, infectious, neoplastic, vascular, metabolic, and traumatic origin. Making the ...

A cell therapy for regenerating broken spinal cord using lab-grown neurons enters human trials for the first time.

Abstract: In this paper, we propose a novel three-ring capacitive angular position sensor with an absolute zero position feature based on microelectromechanical system (MEMS) technology. The sensor ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...

The axolotl is renowned for its extensive ability to regenerate organs and body parts, including its spinal cord. Studies on ...

Research teams funded by the National Institutes of Health (NIH) have created a versatile set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord ...